--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About LTRN20261016P1
Biological Technology
Lantern Pharma Inc., was founded on November 7, 2013. The company is a clinical-stage biotechnology company that leverages artificial intelligence (" A.I. "), machine learning and genomic data to simplify drug development processes and enable patients to be treated to benefit from its targeted tumor therapies.
